These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 25914451)

  • 21. Management of Barrett's esophageal carcinoma.
    Miyazaki T; Inose T; Tanaka N; Yokobori T; Suzuki S; Ozawa D; Sohda M; Nakajima M; Fukuchi M; Kato H; Kuwano H
    Surg Today; 2013 Apr; 43(4):353-60. PubMed ID: 23283352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
    Feith M; Stein HJ; Siewert JR
    Surg Oncol Clin N Am; 2006 Oct; 15(4):751-64. PubMed ID: 17030271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
    Cohen DJ; Leichman L
    J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Gastroesophageal Junction Tumors.
    Okereke IC
    Surg Clin North Am; 2017 Apr; 97(2):265-275. PubMed ID: 28325186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH
    Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.
    Hasegawa S; Yoshikawa T; Cho H; Tsuburaya A; Kobayashi O
    World J Surg; 2009 Jan; 33(1):95-103. PubMed ID: 18958523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
    Bösing NM; Heise JW; Goretzki PE; Sarbia M; Röher HD
    Chirurg; 2004 Nov; 75(11):1088-97. PubMed ID: 15168031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
    Urabe M; Ushiku T; Shinozaki-Ushiku A; Iwasaki A; Yamazawa S; Yamashita H; Seto Y; Fukayama M
    Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extent of surgical resection for esophageal and gastroesophageal junction adenocarcinomas.
    Vrouenraets BC; van Lanschot JJ
    Surg Oncol Clin N Am; 2006 Oct; 15(4):781-91. PubMed ID: 17030273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of the esophago-gastric junction adenocarcinoma].
    Bîrlă R; Losif C; Gîndea C; Hoară P; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(2):143-53. PubMed ID: 18457092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of the pathologist in the processing of adenocarcinoma of the stomach, oesophagogastric junction and lower third of the oesophagus].
    Svrcek M; Fléjou JF
    Ann Pathol; 2011 Dec; 31(6):419-26. PubMed ID: 22172114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Challenges and limits for endoscopic resection of oesophageal and oesophagogastric cancer].
    Behrens A; Ell C
    Zentralbl Chir; 2014 Feb; 139(1):28-31. PubMed ID: 24585194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroesophageal junction adenocarcinoma.
    Swisher SG; Pisters PW; Komaki R; Lahoti S; Ajani JA
    Curr Treat Options Oncol; 2000 Dec; 1(5):387-98. PubMed ID: 12057146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carcinomas of the esophago-gastric junction: surgical strategies].
    Siegel G; Wagner M; Seiler Ch
    Swiss Surg; 2003; 9(3):121-6. PubMed ID: 12815832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment approaches to esophagogastric junction tumors.
    Kurokawa Y; Sasako M; Doki Y
    Dig Surg; 2013; 30(2):169-73. PubMed ID: 23867594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
    Mönig SP; Schröder W; Beckurts KT; Hölscher AH
    Hepatogastroenterology; 2001; 48(41):1231-7. PubMed ID: 11677937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of the COVID-19 Pandemic on Barrett's Esophagus and Esophagogastric Cancer.
    Turkington RC; Lavery A; Donnelly D; Cairnduff V; McManus DT; Coleman HG
    Gastroenterology; 2021 May; 160(6):2169-2171.e1. PubMed ID: 33513406
    [No Abstract]   [Full Text] [Related]  

  • 39. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
    Shaheen NJ; Spechler SJ
    Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
    [No Abstract]   [Full Text] [Related]  

  • 40. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.